1. Home
  2. ALLO vs NWFL Comparison

ALLO vs NWFL Comparison

Compare ALLO & NWFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLO
  • NWFL
  • Stock Information
  • Founded
  • ALLO 2017
  • NWFL 1870
  • Country
  • ALLO United States
  • NWFL United States
  • Employees
  • ALLO N/A
  • NWFL N/A
  • Industry
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • NWFL Major Banks
  • Sector
  • ALLO Health Care
  • NWFL Finance
  • Exchange
  • ALLO Nasdaq
  • NWFL Nasdaq
  • Market Cap
  • ALLO 231.9M
  • NWFL 228.7M
  • IPO Year
  • ALLO 2018
  • NWFL 1998
  • Fundamental
  • Price
  • ALLO $1.11
  • NWFL $26.60
  • Analyst Decision
  • ALLO Strong Buy
  • NWFL Buy
  • Analyst Count
  • ALLO 10
  • NWFL 3
  • Target Price
  • ALLO $8.88
  • NWFL $28.50
  • AVG Volume (30 Days)
  • ALLO 3.8M
  • NWFL 25.0K
  • Earning Date
  • ALLO 11-06-2025
  • NWFL 10-27-2025
  • Dividend Yield
  • ALLO N/A
  • NWFL 4.67%
  • EPS Growth
  • ALLO N/A
  • NWFL N/A
  • EPS
  • ALLO N/A
  • NWFL 0.37
  • Revenue
  • ALLO N/A
  • NWFL $53,958,000.00
  • Revenue This Year
  • ALLO N/A
  • NWFL $80.10
  • Revenue Next Year
  • ALLO $100.00
  • NWFL $28.45
  • P/E Ratio
  • ALLO N/A
  • NWFL $72.51
  • Revenue Growth
  • ALLO N/A
  • NWFL N/A
  • 52 Week Low
  • ALLO $0.86
  • NWFL $21.25
  • 52 Week High
  • ALLO $3.78
  • NWFL $34.50
  • Technical
  • Relative Strength Index (RSI)
  • ALLO 44.66
  • NWFL 65.14
  • Support Level
  • ALLO $1.06
  • NWFL $26.31
  • Resistance Level
  • ALLO $1.18
  • NWFL $27.23
  • Average True Range (ATR)
  • ALLO 0.08
  • NWFL 0.53
  • MACD
  • ALLO 0.01
  • NWFL 0.08
  • Stochastic Oscillator
  • ALLO 31.25
  • NWFL 79.05

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About NWFL Norwood Financial Corp.

Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.

Share on Social Networks: